Home Letrozole combined with rhGH treatment increases the adult height of short pubertal boys
Article
Licensed
Unlicensed Requires Authentication

Letrozole combined with rhGH treatment increases the adult height of short pubertal boys

  • Mingming He , Yanhong Zhang , Qianqian Zhao , Dongye He , Yanying Li , Mei Zhang and Bo Ban EMAIL logo
Published/Copyright: November 30, 2023

Abstract

Objectives

This study was performed to investigate the effectiveness of the combination of letrozole and recombinant human growth hormone (rhGH) to improve the predicted adult height (PAH) and final adult height (FAH) of Chinese short pubertal boys.

Methods

In total, 171 Chinese short pubertal boys were recruited for this study. 96 of them received letrozole (2.5 mg/d) combined with rhGH (33.3–66.6 μg/kg.d), and the others received rhGH alone. Follow-up visits were conducted at 1, 3, 6, 9, and 12 months or regularly after the first treatment. During each visit, plasma samples were collected for clinical tests and biomedical analyses, all of which were performed according to standard protocols. This study was registered at www.chictr.org.cn under ID number ChiCTR1900026142.

Results

After receiving treatment for at least 3 months, 68 boys (91 %) in the rhGH therapy group and 90 (94 %) in the letrozole combined with rhGH (letrozole+rhGH) therapy group achieved an increase in PAH, with the latter treatment leading to a more effective slowing of bone age (BA) advancement. Moreover, the increased PAH showed a significant positive correlation with treatment time in both groups, and letrozole+rhGH increased the PAH to a greater degree than rhGH alone (p=0.0023). And letrozole+rhGH not only slowed the increase in BA more efficiently than rhGH therapy alone (p=0.0025), but also achieved a higher FAH (p=0.0078).

Conclusions

Letrozole combined with rhGH treatment is a promising therapy to increase the PAH and FAH of Chinese short pubertal boys.


Corresponding author: Bo Ban, Department of Endocrinology, Affiliated Hospital of Jining Medical University, Jining Medical University, 89 Guhuai Road 272029, Jining, Shandong, P.R. China, and Chinese Research Center for Behavior Medicine in Growth and Development, 89 Guhuai Road 272029, Jining, Shandong, P.R. China, and National Human Genetic Resources Sharing Service Platform, Jining, Shandong, P.R. China, Phone: +86 0537 2903007, Fax: +86 0537 2903007, E-mail:

Funding source: Jining Science and Technology Bureau

Award Identifier / Grant number: 2017SMNS007

Acknowledgments

We want to thank Jining Science and Technology Bureau for grant support.

  1. Research ethics: This study was conducted according to the principles expressed in the Declaration of Helsinki. All experiments were performed under the approval issued by the Ethics Committee of the Affiliated Hospital of Jining Medical University (NO. 2019JYFY-009), and registered at www.chictr.org.cn (ID number ChiCTR1900026142 on 23/09/2019). And, all methods and all experimental protocols were carried out in accordance with relevant guidelines and regulations.

  2. Informed consent: Informed consent was obtained from all individuals or their legal guardian(s) included in this study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. The project was designed by M.H., Y.Z. and B.B. Material preparation, data collection, and analyses were performed by M.H., Y.Z., Q.Z., D.H., Y.L., and M.Z. The manuscript was written by M.H. and B.B.

  4. Competing interests: Authors state no conflict of interest.

  5. Research funding: This study was supported by the Jining Science and Technology Bureau (No. 2017SMNS007).

  6. Data availability: The data and materials used to support the findings of this study are available from the corresponding author upon request.

References

1. Mauras, N. Strategies for maximizing growth in puberty in children with short stature. Endocrinol Metab Clin North Am 2009;38:613–24. https://doi.org/10.1016/j.ecl.2009.06.004.Search in Google Scholar PubMed

2. Varimo, T, Toiviainen-Salo, S, Raivio, T, Kerttula, L, Dunkel, L, Hero, M. Letrozole monotherapy in pre- and early-pubertal boys does not increase adult height. Front Endocrinol 2019;10:201. https://doi.org/10.3389/fendo.2019.00201.Search in Google Scholar PubMed PubMed Central

3. Wit, JM, Hero, M, Nunez, SB. Aromatase inhibitors in pediatrics. Nat Rev Endocrinol 2011;8:135–47. https://doi.org/10.1038/nrendo.2011.161.Search in Google Scholar PubMed

4. McGrath, N, O’Grady, MJ. Aromatase inhibitors for short stature in male children and adolescents. Cochrane Database Syst Rev 2013;12:CD010888. https://doi.org/10.1002/14651858.CD010888.Search in Google Scholar

5. McGrath, N, O’Grady, MJ. Aromatase inhibitors for short stature in male children and adolescents. Cochrane Database Syst Rev 2015;10:CD010888. https://doi.org/10.1002/14651858.cd010888.pub2.Search in Google Scholar

6. Hero, M. Aromatase inhibitors in the treatment of short stature. Endocr Rev 2016;30:130–40. https://doi.org/10.1159/000439338.Search in Google Scholar PubMed

7. Ferris, JA, Geffner, ME. Are aromatase inhibitors in boys with predicted short stature and/or rapidly advancing bone age effective and safe? J Clin Endocrinol Metab 2017;30:311–7. https://doi.org/10.1515/jpem-2016-0219.Search in Google Scholar PubMed

8. Zhou, P, Shah, B, Prasad, K, David, R. Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency. Pediatrics 2005;115:e245–8. https://doi.org/10.1542/peds.2004-1536.Search in Google Scholar PubMed

9. Neely, EK, Kumar, RB, Payne, SL, Ranadive, SA, Suchet, DI. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data. J Clin Endocrinol Metab 2014;99:4086–93. https://doi.org/10.1210/jc.2014-2432.Search in Google Scholar PubMed

10. Mauras, N, Ross, JL, Gagliardi, P, Yu, YM, Hossain, J, Permuy, J, et al.. Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature. J Clin Endocrinol Metab 2016;101:4984–93. https://doi.org/10.1210/jc.2016-2891.Search in Google Scholar PubMed PubMed Central

11. Pedrosa, LF, de Oliveira, JM, Thome, PRV, Kochi, C, Damiani, D, Longui, CA. Height increment and laboratory profile of boys treated with aromatase inhibitors with or without growth hormone. Horm Metab Res 2017;49:778–85. https://doi.org/10.1055/s-0043-116944.Search in Google Scholar PubMed

12. Rothenbuhler, A, Linglart, A, Bougnères, P. A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature. Int J Pediatr Endocrinol 2015;2015:4. https://doi.org/10.1186/1687-9856-2015-4.Search in Google Scholar PubMed PubMed Central

13. Mauras, N, Ross, J, Mericq, V. Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical Review. Endocr Rev 2023;44:1–13. https://doi.org/10.1210/endrev/bnac014.Search in Google Scholar PubMed

14. Zhang, Y-Y, Liu, P-Y, Lu, Y, Davies, KM, Dvornyk, V, Recker, RR, et al.. Race and sex differences and contribution of height: a study on bone size in healthy Caucasians and Chinese. Am J Hum Biol 2005;17:568–75. https://doi.org/10.1002/ajhb.20427.Search in Google Scholar PubMed

15. Hero, M, Ankarberg-Lindgren, C, Taskinen, MR, Dunkel, L. Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition. Eur J Endocrinol 2006;155:453–60. https://doi.org/10.1530/eje.1.02226.Search in Google Scholar PubMed

16. CUI Yun-Pu, WX-L, Wang, XL. Clinical effect of letrozole in treatment of idiopathic short stature in adolescent boys. Zhongguo dang dai er ke za zhi 2019;21:977–82. https://doi.org/10.7499/j.issn.1008-8830.2019.10.005.Search in Google Scholar PubMed PubMed Central

17. Thodberg, HH, Jenni, OG, Caflisch, J, Ranke, MB, Martin, DD. Prediction of adult height based on automated determination of bone age. J Clin Endocrinol Metab 2009;94:4868–74. https://doi.org/10.1210/jc.2009-1429.Search in Google Scholar PubMed

18. Ji, B, Zhang, M, Zhao, Q, Chu, Y, Li, Y, Pan, H, et al.. Association between alanine aminotransferase and growth hormone: a retrospective cohort study of short children and adolescents. BioMed Res Int 2019;2019:5939372. https://doi.org/10.1155/2019/5939372.Search in Google Scholar PubMed PubMed Central

19. Zhang, Y, Zhang, M, Chu, Y, Ji, B, Shao, Q, Ban, B. Association between growth hormone-insulin-like growth factor-1 axis gene polymorphisms and short stature in Chinese children. BioMed Res Int 2018;2018:7431050. https://doi.org/10.1155/2018/7431050.Search in Google Scholar PubMed PubMed Central

20. Li, Y, Zhang, Y, Zhang, M, Yang, W, Ji, B, Pan, H, et al.. Growth hormone peak modifies the effect of BMI on increased systolic blood pressure in children with short stature. Sci Rep 2019;9:7879. https://doi.org/10.1038/s41598-019-44299-9.Search in Google Scholar PubMed PubMed Central

21. Stanhope, R. Use of a specific aromatase inhibitor in delayed puberty. Lancet 2001;357:1723–4. https://doi.org/10.1016/s0140-6736(00)04930-8.Search in Google Scholar PubMed

22. Ranke, MB. Treatment of children and adolescents with idiopathic short stature. Nat Rev Endocrinol 2013;9:325–34. https://doi.org/10.1038/nrendo.2013.71.Search in Google Scholar PubMed

23. Skuse, D, Gilmour, J, Tian, C, Hindmarsh, P. Psychosocial assessment of children with short stature: a preliminary report. Acta Paediatr 1994;83(s406):11–6. https://doi.org/10.1111/j.1651-2227.1994.tb13413.x.Search in Google Scholar PubMed

24. Peck, MN, Lundberg, O. Short stature as an effect of economic and social conditions in childhood. Soc Sci Med 1995;41:733–8. https://doi.org/10.1016/0277-9536(94)00379-8.Search in Google Scholar PubMed

Received: 2023-10-14
Accepted: 2023-11-13
Published Online: 2023-11-30
Published in Print: 2024-01-29

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Mini Review
  3. Outcomes and experiences of adults with congenital hypogonadism can inform improvements in the management of delayed puberty
  4. Original Articles
  5. Very elevated serum copeptin concentrations occur in a subset of healthy children in the minutes after phlebotomy
  6. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study
  7. MicroRNA-29a and microRNA-122 expressions and other inflammatory markers among obese children with diabetes
  8. Health related quality of life is associated with gastroesophageal reflux symptoms in overweight children
  9. Experience with carnitine palmitoyltransferase II deficiency: diagnostic challenges in the myopathic form
  10. Gender-related differences in cardiometabolic risk factors and oxidative stress among prepubertal children with obesity
  11. Recurrence and survival for patients with thyroid carcinoma in the pediatric age group in the Emirate of Abu Dhabi: retrospective analysis of a multicentre cohort
  12. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty
  13. Ambulatory blood pressure monitorisation in children with recombinant growth hormone treatment
  14. Letrozole combined with rhGH treatment increases the adult height of short pubertal boys
  15. Case Reports
  16. Hypothalamic-pituitary dysfunction in Sturge–Weber syndrome: case report and review of the literature
  17. Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal STX16 deletion
Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2023-0459/html
Scroll to top button